Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
March 21st is Anal Cancer Awareness Day
Friends, siblings, support groups and social media can all make a huge difference for patients who are “cancering” on their own.
Topical treatment may be as effective as electrocautery for anal neoplasia but with fewer adverse effects.
LGBTQ disparities exist in cervical cancer prevention—including HPV vaccines—and in rates of anal cancer, notably among those with HIV.
Chemotherapy drugs in short supply are essential for treating esophageal, pancreatic and colon cancer.
Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.
Human papillomavirus, a common sexually transmitted infection, can cause cervical, anal, and oral cancers.
Vaccines could potentially eliminate cervical, anal, oral and other cancers caused by human papillomavirus.
Prompt detection treatment of precancerous lesions cut the likelihood of developing anal cancer by more than half.
Certain types of human papillomavirus cause almost all cases of cervical cancer.
A pilot program is assessing whether self-testing for the cancer-causing virus can reach women who otherwise might not get screened.
Prompt treatment of precancerous lesions in people with HIV reduced the likelihood of developing anal cancer by 57%.
A look back at some of the most important science and treatment news Cancer Health covered this year.
Early vaccination reduces the risk of cervical cancer by nearly 90%, but many young people remain unprotected.
Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.